<p>This interview discusses the use of lithium, thyroid hormone, second-generation antipsychotics, newer antidepressants, and ketamine/esketamine as adjunctive agents in managing major depressive disorder.</p>        Faculty: Michael Thase, M.D.         <ul> <li class="c-message_actions__group" role="group" aria-label= "Accesos directos de mensaje" data-qa="message-actions"><a href= "https://psychopharmacologyinstitute.com/cme-program?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC049"> Learn more about Premium Membership here</a></li> <li class="c-message_actions__group" role="group" aria-label= "Accesos directos de mensaje" data-qa="message-actions"> <a href= "https://psychopharmacologyinstitute.com/publication/top-10-drug-combinations-in-mdd-interview-2577?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC049"> Earn 0.75 CMEs - "Top 10 Drug Combinations in MDD - Interview with Prof. Michael E. Thase"</a></li> </ul>

Lithium: Sexual Side Effects and Cognitive Impairment

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.